← Back to Newsletter Archive

Greetings!

Welcome to the Monthly QPS Preclinical Newsletter


Gain confidence with QPS experts support of IND-enabling studies and oligonucleotide drug development, and learn valuable industry perspectives on chronic pain and Lyme disease in the latest articles on the QPS Blog.

QPS: Your End-to-End Partner for IND Success

QPS provides comprehensive IND-enabling study programs designed to support successful regulatory submissions and accelerate the path to first-in-human clinical trials.


Partner with QPS to streamline drug development through expert scientific guidance, rapid study execution, and proven regulatory expertise from preclinical research through First-in-Human studies.

Contact our team to discuss how we can help advance your development program.

Dive Into the White Paper

Confidently Choose A CRO to Support Your IND Efforts

Stay Ahead of Emerging Challenges in Oligonucleotide Drug Development

Therapeutic oligonucleotides are transforming the treatment of complex diseases, but understanding their metabolism is critical to advancing safe and effective therapies.


This QPS white paper highlights strategies for metabolite identification, profiling, and quantitation that help sponsors navigate development challenges and generate the data needed to support successful drug programs.

Explore the Full Report

Therapeutic Oligonucleotide Metabolite Identification, Profiling and Quantitation

Discover the Future of Science on the QPS Blog

Flipping a Switch to Stop Chronic Pain



Public health experts estimate that up to 10 percent of adults are newly diagnosed with chronic pain, or ongoing pain that lasts longer than…



Mapping Chronic Pain Pathways

QPS Clinical Trial Services

Clinical Trial Results Revive Long-Awaited Lyme Disease Vaccine Effort


After more than two decades without a human vaccine for Lyme disease, a new candidate is showing measurable progress. Clinical trial data reported by…


A New Chapter in Lyme Prevention

More Vaccine Research at QPS

Contact the Experts at QPS

 

Request a meeting with QPS preclinical, bioanalysis, translational medicine, and/or clinical research subject matter experts today. 

Visit our website www.qps.com 

or contact us at infopr@qps.com

to start your next study.

Linkedin  Youtube  X  Facebook

View as Webpage

www.qps.cominfopr@qps.com

We use your email address exclusively for sending QPS newsletters with a special e-mail program. If you no longer wish to receive any mailings, simply use the "unsubscribe" link at the bottom. If you don't unsubscribe, we assume that this consent also applies to the system of the GDPR. (Data protection notice: According to Art. 7 GDPR, the consent can of course also be withdrawn at any time after May 25, 2018.)
← Back to Newsletter Archive